India Globalization Capital, Inc. announced that Carrolee Barlow, MD, PhD has been appointed to the company as an Advisor to help develop solutions and treatments for Parkinson’s disease utilizing cannabis related formulations. Dr. Barlow is a renowned expert in neuroscience & neurodegeneration and is currently the CEO of the Parkinson’s Institute and Clinical Center. Dr. Barlow’s illustrious career has focused on clinical care, laboratory and clinical research, academia and industry. She is the founder and former Chief Scientific Officer and Chief Medical Officer of BrainCells, Inc. She serves as an advisory board member for several biotechnology companies and disease foundations.